日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[(18)F]TFB PET/CT misses intense [(124)I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer

在转移性甲状腺癌的再分化治疗后,[(18)F]TFB PET/CT 漏诊了高[(124)I]碘摄取的转移灶

Backhaus, Philipp; Pentlow, Keith S; Ho, Alan L; Mauguen, Audrey; Fagin, James A; Pillarsetty, Naga Vara Kishore; Lyashchenko, Serge K; Burnazi, Eva; Ghossein, Ronald A; Chhabra, Shalini; Abusamra, Murad; Larson, Steven M; Schöder, Heiko; O'Donoghue, Joseph; Weber, Wolfgang; Grewal, Ravinder K

8299 A Case of Hypoglycemia in a Patient with Cirrhosis and Previous Bariatric Surgery

8299 一例肝硬化合并既往接受过减肥手术的患者发生低血糖的病例

Calne, R Y; Williams, R; Dawson, J L; Ansell, I D; Evans, D B; Flute, P T; Herbertson, P M; Joysey, V; Keates, G H; Knill-Jones, R P; Mason, S A; Millard, P R; Pena, J R; Pentlow, B D; Salaman, J R; Sells, R A; Cullum, P A; Risbud, A; Bao, G; Kirkeby, K M

Radioimmunoscintigraphy and Pretreatment Dosimetry of (131)I-Omburtamab for Planning Treatment of Leptomeningeal Disease

放射免疫闪烁显像和 (131)I-Omburtamab 预处理剂量测定用于软脑膜疾病的治疗计划

Pandit-Taskar, Neeta; Grkovski, Milan; Zanzonico, Pat B; Pentlow, Keith S; Modak, Shakeel; Kramer, Kim; Humm, John L

Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial

使用维莫非尼和抗ErbB3单克隆抗体CDX-3379增强BRAF突变型、放射性碘难治性甲状腺癌的放射性碘摄取:一项初步临床试验的结果

Tchekmedyian, Vatche; Dunn, Lara; Sherman, Eric; Baxi, Shrujal S; Grewal, Ravinder K; Larson, Steven M; Pentlow, Keith S; Haque, Sofia; Tuttle, R Michael; Sabra, Mona M; Fish, Stephanie; Boucai, Laura; Walters, Jamie; Ghossein, Ronald A; Seshan, Venkatraman E; Knauf, Jeffrey A; Pfister, David G; Fagin, James A; Ho, Alan L

Optimizing reconstruction parameters for quantitative (124)I-PET in the presence of therapeutic doses of (131)I

在存在治疗剂量 (131)I 的情况下,优化定量 (124)I-PET 的重建参数

Fanchon, Louise M; Beattie, Bradley J; Pentlow, Keith; Larson, Steven M; Humm, John L

A novel fixation method for unstable ankle fractures in the elderly using dual percutaneous tibiotalar cannulated screws

一种用于治疗老年人不稳定踝关节骨折的新型固定方法:采用双侧经皮胫距空心螺钉

Hancock, Daniel W; Hainsworth, Louis; Pentlow, Alanna K

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

维莫非尼诱导BRAF突变型、放射性碘难治性甲状腺癌再分化

Dunn, Lara A; Sherman, Eric J; Baxi, Shrujal S; Tchekmedyian, Vatche; Grewal, Ravinder K; Larson, Steven M; Pentlow, Keith S; Haque, Sofia; Tuttle, R Michael; Sabra, Mona M; Fish, Stephanie; Boucai, Laura; Walters, Jamie; Ghossein, Ronald A; Seshan, Venkatraman E; Ni, Ai; Li, Duan; Knauf, Jeffrey A; Pfister, David G; Fagin, James A; Ho, Alan L

Biodistribution and Dosimetry of Intraventricularly Administered (124)I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors

脑室内注射 (124)I-Omburtamab 在转移性软脑膜肿瘤患者中的生物分布和剂量学

Pandit-Taskar, Neeta; Zanzonico, Pat B; Kramer, Kim; Grkovski, Milan; Fung, Edward K; Shi, Weiji; Zhang, Zhigang; Lyashchenko, Serge K; Fung, Alex M; Pentlow, Keith S; Carrasquillo, Jorge A; Lewis, Jason S; Larson, Steven M; Cheung, Nai-Kong V; Humm, John L

A recommendation for revised dose calibrator measurement procedures for 89Zr and 124I

关于修订 89Zr 和 124I 剂量校准器测量程序的建议

Beattie, Bradley J; Pentlow, Keith S; O'Donoghue, Joseph; Humm, John L

Quantitative modeling of Cerenkov light production efficiency from medical radionuclides

医用放射性核素切伦科夫光产生效率的定量建模

Beattie, Bradley J; Thorek, Daniel L J; Schmidtlein, Charles R; Pentlow, Keith S; Humm, John L; Hielscher, Andreas H